Search filters

List of works by Elisa A Rozeman

Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives.

scientific article published on 21 November 2017

Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors

scientific article published on 13 November 2018

B cells and tertiary lymphoid structures promote immunotherapy response

scientific article published on 15 January 2020

Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy

scientific article published on 22 November 2018

Cancer drug addiction is relayed by an ERK2-dependent phenotype switch

scientific article published on 4 October 2017

Combining checkpoint inhibition and targeted therapy in melanoma

scientific article published on 01 June 2019

Comprehensive analysis of cutaneous and uveal melanoma liver metastases

scientific article published on 01 December 2020

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.

scientific article published on 15 January 2018

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

scientific article published on 01 July 2019

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma

scientific article published on 27 December 2018

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma

scientific article published on 01 April 2020

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis

scientific article published on 26 February 2019

Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls

scientific article published on 14 September 2020

Identification of CMTM6 and CMTM4 as PD-L1 protein regulators.

scientific article

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

scientific article published on 31 May 2019

Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management.

scientific article

Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

scientific article published on 01 July 2019

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

scientific article published on 08 October 2018

Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies.

scientific article

Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)

scientific article published on 21 January 2020

Predicting Response to Cancer Immunotherapy using Non-invasive Radiomic Biomarkers

scientific article published on 01 June 2019

Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4

scientific article published on 06 July 2021

Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy

scientific article published on 01 October 2019

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

scientific article published on 07 August 2020

Short-term CTLA-4 blockade directly followed by PD-1 blockade in advanced melanoma patients: a single-center experience

scientific article

Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma

scientific article published on 18 March 2019

Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events

scientific article published on 21 July 2019

Switch to checkpoint inhibition after targeted therapy at time of progression or during ongoing response: A retrospective single-centre experience in patients with BRAF-mutated melanoma

scientific article published on 23 October 2019

Targeting tumor-associated acidity in cancer immunotherapy

scientific article published on 05 July 2018

The human tumor microbiome is composed of tumor type-specific intracellular bacteria

scientific article

Paulina is supported by:

About Paulina

Help